 23. The participant has systolic blood pressure 80 mmHg or diastolic blood pressure 45 mmHg, or systolic blood pressure 160 mmHg or diastolic blood pressure 100 mmHg at the time of screening, baseline examination or examination prior to administration of the study drug. 